MAPK1 and breast cancer: Furthermore, mutant ERK2 dramatically increased the migration and invasion of MDA-MB-231 cells (Fig. 5H and I), indicating that blockade of ERK2 SUMOylation contributed to tumorigenesis of breast cancer.